Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Neovacs    ALNEV   FR0004032746

NEOVACS (ALNEV)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
02/02/2016 02/03/2016 02/04/2016 02/05/2016 02/08/2016 Date
1.27(c) 1.25(c) 1.25(c) 1.25(c) 1.18 Last
1 445 329 660 969 675 124 203 599 481 476 Volume
-7.97% -1.57% 0.00% 0.00% -5.60% Change
More quotes
Financials (€)
Sales 2015 0,10 M
EBIT 2015 -10,3 M
Net income 2015 -8,15 M
Finance 2015 2,00 M
Yield 2015 -
Sales 2016 0,10 M
EBIT 2016 -11,3 M
Net income 2016 -9,15 M
Debt 2016 4,00 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 381x
EV / Sales 2016 441x
Capitalization 40,1 M
More Financials
Company
Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory, and cancerous diseases.It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis, and... 
Sector
Biotechnology & Medical Research
Calendar
02/08 | 11:30amPresentation
More about the company
Surperformance© ratings of Neovacs
Trading Rating : - Investor Rating :
More Ratings
Latest news on NEOVACS
01/29 NEOVACS : 2016 Financial Calendar (DGAP News)
01/29 NEOVACS : 2016 Financial Calendar
01/22 NEOVACS : Associates Stellar Biotechnologies in Its Industrial Project
01/21 NEOVACS : associates Stellar Biotechnologies in its industrial Project
01/21 NEOVACS : associates Stellar Biotechnologies in its industrial Project (DGAP New..
01/20 NEOVACS : Stellar Biotech and Neovacs to Form Joint Venture
01/08 NEOVACS : Half-year report on the liquidity contract
01/06 NEOVACS : secures €5 million from the public funding program «Investments for th..
More news
Sector news : Biotechnology & Medical Research - NEC
07:31a SANOFI : Appoints muzammil mansuri to executive committee and executive vice pre..
02/07 CELGENE, GILEAD SCIENCES SHARES COUL : Barron's
02/07DJDrug Industry Launches Ad Campaign Aimed at Lawmakers
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart NEOVACS
Duration : Period :
Neovacs Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions